ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1925

Interest of Procalcitonin for the Follow-up of ANCA-Associated Vasculitis: Data from a Cohort of 99 Patients

Anne Lemaire1, Roderau Outh1, Alexandre Mania1, Geoffroy Marceau2, Pauline Berland3, Marc Andre4 and Olivier Aumaître5, 1Internal Medicine CHU G Montpied, Internal Medicine, CLERMONT-FERRAND, France, 2Biology, Medical Biochemistry, CLERMONT-FERRAND, France, 3Epidemiology, Epidemiology, CLERMONT-FERRAND, France, 4Internal Medicine CHU G Montpied, Internal Medicine, Clermont Ferrand, France, 5Division of internal Medicine, Centre Hospitalier Universitaire, Hôpital Gabriel Montpied, Clermont–Ferrand, Clermont–Ferrand, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ANCA, Infection, inflammation and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Vasculitis - Poster II: ANCA-Associated Vasculitis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:   The prognosis of the ANCA associated vasculitis (AAV) has improved with the new immunosuppressive treatments but infectious complications remain frequent. Procalcitonin (PCT) is used for a quick diagnosis of bacterial infection. The aim of this study was to assess the diagnostic accuracy of PCT for the differential diagnoses of a bacterial infection from a vasculitis flare.

Methods:  All patients with a granulomatosis with polyangiitis (GPA), a eosinophilic granulomatosis with polyangiitis (EGPA) or a microscopic polyangiitis (MPA) followed in our internal medicine department were included. PCT was determined by KRYPTOR assay (Thermo Fisher BRAHMS). All bacterial infections or flares up of the vasculitis were recorded. The diagnosis of flare up was based on increase of the BVAS or the BVAS WEG. Infections were confirmed by a positive microbial test or an evidence of infection on imaging. For the cases without evidence of positive microbial test, the diagnosis was established when two out of three practitioners of the unit gave the same opinion.

Results:  The cohort consisted of 99 AAV (GPA = 73; EGPA = 21; MPA = 5). The follow up was of 5 years [1,8 ; 9,2]. 53 patients experienced 96 flare ups. Those were GPA in 70% of cases. 57 patients developed 74 bacterial infections. 11 were excluded because of a lack of proof. 27 had a positive microbial test. The value of PCT was found for 55,4% of the registered events. PCT was higher in cases of bacterial infection than flare up (0,3 µg/l [0,11 ; 1,9] vs 0,08 µg/l [0,05 ; 0,13], p<0,0001). The same results were found for the bacterial infection with a proof by positive microbial test (0,55 µg/l [0,13 ; 3] vs 0,08 [0,05 ; 0,13], p=0,0021). For a threshold in 0,11µg/l, the sensibility and the specificity of the PCT were of 75% and 73,5% respectively. For a threshold of 48mg/l, the sensibility of the CRP was 71,4% and the specificity was 62,8%.

Conclusion:  Five retrospective studies were carried on this subject. For two studies, the result seems to show an increase of procalcitonin during active vasculitis. But this result is inconstant and uncertain. Three studies found results similar to ours; during bacterial infections, the PCT increase more than during flares. Therefore, a modification of the discriminant threshold could allow the using of this marker to distinguish a flare up of infection. One study that used the same assay to determine the PCT, showed that a threshold of 0,1 µg/l was effective. The accuracy of PCT for the diagnosis of bacterial infection in patients with AAV is better than CRP. PCT seems to be useful to distinguish a flare up from a bacterial infection although PCT rises too in flare up.


Disclosure: A. Lemaire, None; R. Outh, None; A. Mania, None; G. Marceau, None; P. Berland, None; M. Andre, None; O. Aumaître, None.

To cite this abstract in AMA style:

Lemaire A, Outh R, Mania A, Marceau G, Berland P, Andre M, Aumaître O. Interest of Procalcitonin for the Follow-up of ANCA-Associated Vasculitis: Data from a Cohort of 99 Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/interest-of-procalcitonin-for-the-follow-up-of-anca-associated-vasculitis-data-from-a-cohort-of-99-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interest-of-procalcitonin-for-the-follow-up-of-anca-associated-vasculitis-data-from-a-cohort-of-99-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology